Phase II Trial of Atezolizumab (anti-PD-L1) in the Treatment of Stage IIb-IV Mycosis Fungoides / Sezary Syndrome Patients Relapsed / Refractory After a Previous Systemic Treatment

Project Details

Short titlePhase II Trial of Atezolizumab (anti-PD-L1) in the Treatment of Stage IIb-IV Mycosis Fungoides / Sezary Syndrome Patients Relapsed / Refractory After a Previous Systemic Treatment
StatusFinished
Effective start/end date16/08/18 → 15/02/20

Funding

  • European Organisation For Research And Treatment Of Cancer